Publications   |   Conferences    |  Join   |  Sitemap  
Facebook    Twitter     Linkedin     RSS     Google+    BLOG    You Tube

Journal of Genetic Syndromes & Gene Therapy

Double blind review in 2 weeks     Publishing in 72 hours after acceptance     Open Access     High Impact
ISSN: 2157-7412
French Language  |  English

In Association with


Welcome to the Journal

Blum Editor-in-Chief
Kenneth Blum, MD, PhD
Professor, Department of Psychiatry
University of Florida, USA
Tel. +619- 890-2167
Marek Editor-in-Chief
Marek Malecki, MD, PhD
President, PBMEF, San Francisco, USA
Tel. 415-713-4370

Impact Factor: 3.67*

ICV: 5.29

Genes are the basic physical and functional units of hereditary and are the specific sequences of bases that are carried on chromosomes which encode instruction, ensure the formation of proteins. Deficiency or disorders of genes in cells leads to the genetic disorders resolved with the respected treatment of gene therapies. The different types of viruses used as gene therapy vectors are retroviruses, adenoviruses, adeno-associated viruses, herpes simplex viruses.
Journal of Genetic Syndromes & Gene Therapy is an international, peer-reviewed scientific journal emphasizes the documentation of phenotype analysis, birth defects; infant abnormalities including the various inheritant disorders caused by single mutant genes and the changes that occur due to therapy are heritable. The Journal of Genetic Syndromes and Gene Therapy under Open Access Category conveys the latest research information on identification and analysis of the defective gene, vector development, gene transfer, and provides the readership with current clinical applications for the treatment of diseases and comprehensive reviews on all aspects of genetic disorders and gene therapy.
Journal of Genetic Syndromes & Gene Therapy is using online manuscript submission, review and tracking systems of Editorial Manager for quality and quick review processing. Review processing is performed by the editorial board members of Journal of Genetic Syndromes and Gene Therapy or outside experts; at least two independent reviewer’s approval followed by editor's approval is required for acceptance of any citable manuscript.

Journal of Genetic Syndromes & Gene Therapy encompasses the continuous coverage of all biological and medical aspects of potential gene therapies for the birth defects along with genetic disorders which include treatments for cancers, arthritis, infectious diseases, inherited diseases like cystic fibrosis and Huntington’s disease, and also genetic abnormalities or deficiencies are treated by incorporating specific engineered genes into the infected cells of patient’s body. The Journal of Genetic Syndromes & Gene Therapy provides reliable information updating online viewers with the modified methods and latest advancements in the field of gene therapy for diverse genetic disorders.


Journal of Genetic Syndromes & Gene Therapy is associated with our international conference "3rd International Conference and Exhibition on Cell & Gene Therapy" (Cell Gene therapy-2014) during October 27-29, 2014, Las Vegas, USA with a theme “Uncover the potential that lies within the cell”. At the forefront cell and gene therapy dives into the latest happenings of the cell – based and genetic technologies and the transdifferentiation progress to treat various diseases. Progressive research domains as of cancer vaccines and their novel significance are showcased which bring into limelight the cutting edge of the field. The Cell and Gene therapy of the coming ages has promised booming results for treating various diseases apparently by using stem cells without causing harmful side effects
* Unofficial 2013 Impact Factor was established by dividing the number of articles published in 2011 and 2012 with the number of times they are cited in 2013 based on Google search and the Scholar Citation Index database. If ‘X’ is the total number of articles published in 2011 and 2012, and ‘Y’ is the number of times these articles were cited in indexed journals during 2013 than, impact factor = X/Y



Recently published articles

Reconstitution with Bone Marrow Cells is Consistently Defective in the Tibia of Aged Monkeys

Susumu Ikehara, Ming Li, Ming Shi, Yunze Cui Kequan Guo and Yasushi Adachi

Eosinophils and Airway Inflammation
Armengot M, Garin L, Peiro T, Milara J, Cortijo J
Four-Year Course of Serum and Cerebrospinal Fluid Antibody Titers in a Patient with Anti-NMDAR Encephalitis
Hiroshi Kataoka, TakanoriKitauti, Yasuyo Kobayashi and Satoshi Ueno
Hiding in Plain Sight: A Consideration of NF1-Associated Hypovitaminosis D and its Treatment

Vincent M. Riccardi

Cystic Fibrosis - An Open Book that must be Always Updated

Sur Genel, Floca Emanuela, Sur M Lucia, Sur Daniel and Miclos M Corina

Hereditary Nephrogenic Diabetes Insipidus: Molecular Basis of the Defect and Potential Novel Strategies for Treatment

Giuseppe Procino, Serena Milano, Monica Carmosino, Andrea Gerbino, Leonilde Bonfrate, Piero Portincasa and Maria Svelto

Stem Cells Transplantation in Myocardial Tissue Induces Pro-arrhythmic Effects and Promotes Reperfusion. Comparison between Intramyocardial and Intravenous Approach

Pennella S, Reggiani Bonetti L, Migaldi M, Farinetti A, Manenti A, Lonardi R, Giuliani E, Panini F and Mattioli AV

Enhanced Expression of N-Formyl Peptide Receptor in Mesenchymal Stem Cells Facilitates Homing to Inflammatory Lungs

Anand Viswanathan and Guoshun Wang

* Calculation of Unofficial Impact Factor
20082014 OMICS Group - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version